Fmr Llc ownership in 038 / NovoCure Limited

NovoCure Limited

DE ˙ DB ˙ JE00BYSS4X48

13,66 € ↑0,85 (6,63%)

2026-06-04
AKTIENPREIS

Security	DE:038 / NovoCure Limited
Institution	Fmr Llc
Latest Disclosed Ownership	15,962,765 shares
Ownership	14.94%

2024-02-09 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15,962,765 shares of NovoCure Limited (DE:038). This represents 14.937 percent ownership of the company. In their previous filing dated 2023-02-09 , Fmr Llc had reported owning 15,743,514 shares, indicating an increase of 1.39 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2024-02-09	2024-02-09	13G/A	15,743,514	15,962,765	1.39	14.94	-0.41
2023-02-09	2023-02-09	13G/A	10,736,704	15,743,514	46.63	15.00	45.89
2022-04-11	2022-04-11	13G/A	7,810,337	10,736,704	37.47	10.28	36.68
2022-02-09	2022-02-09	13G/A	9,645,386	7,810,337	-19.03	7.52	-20.60
2021-02-08	2021-02-08	13G/A	12,179,428	9,645,386	-20.81	9.47	-23.02
2020-02-07	2020-02-07	13G/A	11,190,380	12,179,428	8.84	12.31	2.29
2019-02-13	2019-02-13	13G/A	9,944,373	11,190,380	12.53	12.03	12.39
2018-09-10	2018-09-10	13G/A	8,070,440	9,944,373	23.22	10.70	18.54
2018-02-13	2018-02-13	13G/A	4,889,661	8,070,440	65.05	9.03	60.28
2017-02-14	2017-02-14	13G/A	5,183,303	4,889,661	-5.67	5.63	-10.13
2016-08-10	2016-08-10	13G		5,183,303		6.27

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	NOVOCURE	ORD SHS	G6674U108	17,069,149	272,170	1.62	186,054	-14.33	0.0019
2026-02-17	2025-12-31	13F	NOVOCURE	ORD SHS	G6674U108	16,796,979	27,101	0.16	217,185	0.24	0.0111
2025-11-13	2025-09-30	13F	NOVOCURE	ORD SHS	G6674U108	16,769,878	47,123	0.28	216,667	-27.21	0.0113
2025-08-14	2025-06-30	13F	NOVOCURE	ORD SHS	G6674U108	16,722,755	235,477	1.43	297,665	1.31	0.0168
2025-05-12	2025-03-31	13F	NOVOCURE	ORD SHS	G6674U108	16,487,278	257,139	1.58	293,803	-39.25	0.0188
2025-02-13	2024-12-31	13F	NOVOCURE	ORD SHS	G6674U108	16,230,139	-1,869	-0.01	483,658	90.64	0.0289
2024-11-13	2024-09-30	13F	NOVOCURE	ORD SHS	G6674U108	16,232,008	90,422	0.56	253,706	-8.25	0.0154
2024-08-13	2024-06-30	13F	NOVOCURE	ORD SHS	G6674U108	16,141,586	77,618	0.48	276,505	10.13	0.0177
2024-05-13	2024-03-31	13F	NOVOCURE	ORD SHS	G6674U108	16,063,968	101,201	0.63	251,080	5.35	0.0169
2024-02-13	2023-12-31	13F	NOVOCURE	ORD SHS	G6674U108	15,962,767	3,219	0.02	238,324	-7.54	0.0183
2023-11-13	2023-09-30	13F	NOVOCURE	ORD SHS	G6674U108	15,959,548	29,525	0.19	257,747	-61.01	0.0223
2023-08-11	2023-06-30	13F	NOVOCURE	ORD SHS	G6674U108	15,930,023	124,806	0.79	661,096	-30.45	0.0554
2023-08-11	2023-03-31	13F/A-1	NOVOCURE	ORD SHS	G6674U108	15,805,217	68,538	0.44	950,526	-17.65	0.0869
2023-05-11	2023-03-31	13F	NOVOCURE	ORD SHS	G6674U108	15,805,217	68,538		950,526		0.0869
2023-02-13	2022-12-31	13F	NOVOCURE	ORD SHS	G6674U108	15,736,679	296,571	1.92	1,154,285	-1.61	0.1147
2022-11-10	2022-09-30	13F	NOVOCURE	ORD SHS	G6674U108	15,440,108	2,898,102	23.11	1,173,139	34.59	0.1223
2022-08-12	2022-06-30	13F	NOVOCURE	ORD SHS	G6674U108	12,542,006	1,812,136	16.89	871,669	-1.95	0.0869
2022-05-13	2022-03-31	13F	NOVOCURE	ORD SHS	G6674U108	10,729,870	2,926,367	37.50	888,969	51.73	0.0710
2022-02-14	2021-12-31	13F	NOVOCURE	ORD SHS	G6674U108	7,803,503	-471,384	-5.70	585,887	-39.05	0.0433
2022-02-14	2021-09-30	13F/A-1	NOVOCURE	ORD SHS	G6674U108	8,274,887	-1,344,248	-13.97	961,293	-54.95	0.0762
2021-11-15	2021-09-30	13F	NOVOCURE	ORD SHS	G6674U108	8,274,887	-1,344,248		961,293		0.0762
2021-08-13	2021-06-30	13F	NOVOCURE	ORD SHS	G6674U108	9,619,135	530,696	5.84	2,133,717	77.62	0.1672
2021-05-14	2021-03-31	13F	NOVOCURE	ORD SHS	G6674U108	9,088,439	-539,115	-5.60	1,201,310	-27.89	0.1026
2021-02-08	2020-12-31	13F	NOVOCURE	ORD SHS	G6674U108	9,627,554	-328,806	-3.30	1,665,951	50.32	0.1482
2020-11-13	2020-09-30	13F	NOVOCURE	ORD SHS	G6674U108	9,956,360	-482,174	-4.62	1,108,242	79.04	0.1120
2020-08-24	2020-06-30	13F/A-1	NOVOCURE	ORD SHS	G6674U108	10,438,534	-1,400,625	-11.83	619,005	-22.36	0.0681
2020-08-13	2020-06-30	13F	NOVOCURE	ORD SHS	G6674U108	10,438,534	-1,400,625		619,005		15,207.1414
2020-05-14	2020-03-31	13F	NOVOCURE	ORD SHS	G6674U108	11,839,159	-340,270	-2.79	797,248	-22.32	0.1104
2020-02-07	2019-12-31	13F	NOVOCURE	ORD SHS	G6674U108	12,179,429	274,398	2.30	1,026,360	15.29	0.1132
2019-11-13	2019-09-30	13F	NOVOCURE	ORD SHS	G6674U108	11,905,031	1,601,733	15.55	890,258	36.65	0.1068
2019-08-13	2019-06-30	13F	NOVOCURE	ORD SHS	G6674U108	10,303,298	-134,390	-1.29	651,477	29.57	0.0761
2019-05-13	2019-03-31	13F	NOVOCURE	ORD SHS	G6674U108	10,437,688	-752,693	-6.73	502,783	34.20	0.0602
2019-02-13	2018-12-31	13F	NOVOCURE	ORD SHS	G6674U108	11,190,381	345,135	3.18	374,654	-34.07	0.0513
2018-11-09	2018-09-30	13F	NOVOCURE	ORD SHS	G6674U108	10,845,246	2,983,125	37.94	568,292	130.93	0.0639
2018-08-10	2018-06-30	13F	NOVOCURE	ORD SHS	G6674U108	7,862,121	881,776	12.63	246,084	61.72	0.0291
2018-05-14	2018-03-31	13F	NOVOCURE	ORD SHS	G6674U108	6,980,345	-1,085,854	-13.46	152,171	-6.61	0.0181
2018-02-12	2017-12-31	13F	NOVOCURE	ORD SHS	G6674U108	8,066,199	269,264	3.45	162,937	5.28	0.0191
2017-11-13	2017-09-30	13F	NOVOCURE	ORD SHS	G6674U108	7,796,935	908,815	13.19	154,769	29.88	0.0187
2017-08-29	2017-06-30	13F/A-1	NOVOCURE	ORD SHS	G6674U108	6,888,120	2,309,559	50.44	119,165	221.32	0.0148
2017-08-11	2017-06-30	13F	NOVOCURE	ORD SHS	G6674U108	6,888,120	2,309,559		119,165
2017-05-11	2017-03-31	13F	NOVOCURE	ORD SHS	G6674U108	4,578,561	-311,100	-6.36	37,086	-3.38	0.0047
2017-02-10	2016-12-31	13F	NOVOCURE	ORD SHS	G6674U108	4,889,661	10,691	0.22	38,384	-7.88	0.0051
2016-11-14	2016-09-30	13F	NOVOCURE	ORD SHS	G6674U108	4,878,970	-117,051	-2.34	41,666	-28.54	0.0055
2016-08-11	2016-06-30	13F	NOVOCURE	ORD SHS	G6674U108	4,996,021	-529,200	-9.58	58,304	-27.12	0.0080
2016-05-16	2016-03-31	13F	NOVOCURE	ORD SHS	G6674U108	5,525,221	347,818	6.72	80,005	-30.89	0.0111
2016-02-12	2015-12-31	13F	NOVOCURE	ORD SHS	G6674U108	5,177,403	5,177,403		115,767		0.0156

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.